NPY and major depressive disorder: Furthermore, recently demonstrated that intranasal NPY and the NPY Y1 receptor (Y1R) agonist administration had antidepressant effects in rodents (Nahvi et al., 2021; Serova et al., 2017) and in MDD patients (Mathé et al., 2020).